| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |